Myklebost Home

Mesenchymal Cancer Biology Group

Sarcomas are a heterogeneous group of malignant tumours of mesenchymal origin that arise in various types of supporting and connective tissues. Sarcomas are rare, accounting for only 1% of all new malignancies, but 10-15% in young and adolescent patients. Although rare cancers together make up one of the largest patient groups with the by far most lost life-years, therapeutic research is difficult and neglected by industry due to low commercial potential. Thus, with some exceptions, the treatments have not improved significantly the last decades, and new strategies are required to improve outcome for these patients.



Jørgen Wesche started as a group leader from 1st of April, taking over the responsibility after Ola Myklebost who changed his main affiliation to the University of Bergen.